Table 3 Association of admission sex and mineralocorticoid hormone metabolite levels with short- and long-term all-cause mortality in females with CAP
Females (N = 113) | All-cause mortality timepoint | |||||
|---|---|---|---|---|---|---|
30 days | 3 years | 6 years | ||||
HR (95%CI) | p value | HR (95%CI) | p value | HR (95%CI) | p value | |
Progesterone | ||||||
 Cox regression analyses | 0.34 (95%CI 0.004–25.46) | p = 0.621 | 0.24 (95%CI 0.08–0.71) | p = 0.010 | 0.44 (95%CI 0.17–1.14) | p = 0.093 |
17-OH-Progesterone | ||||||
 Cox regression analyses | 0.55 (95%CI 0.09–3.46) | p = 0.528 | 0.99 (95%CI 0.45–2.19) | p = 0.979 | 0.98 (95%CI 0.50–1.93) | p = 0.963 |
Aldosterone | ||||||
 Cox regression analyses | 0.29 (95%CI 0.04–2.14) | p = 0.226 | 0.64 (95%CI 0.30–1.39) | p = 0.263 | 0.81 (95%CI 0.43–1.53) | p = 0.516 |
DHEA | ||||||
 Cox regression analyses |  |  | 1.98 (95%CI 0.33–11.97) | p = 0.456 | 1.44 (95%CI 0.30–6.91) | p = 0.645 |
DHEA-S | ||||||
 Cox regression analyses |  |  | 0.69 (95%CI 0.22–2.19) | p = 0.529 | 0.55 (95%CI 0.23–1.31) | p = 0.178 |
Androstenedione | ||||||
 Cox regression analyses | 1.41 (95%CI 0.31–6.38) | p = 0.652 | 1.03 (95%CI 0.58–1.83) | p = 0.925 | 1.10 (95%CI 0.68–1.79) | p = 0.695 |
Testosterone | ||||||
 Cox regression analyses | 0.92 (95%CI 0.29–2.92) | p = 0.887 | 0.81 (95%CI 0.40–1.67) | p = 0.574 | 0.91 (95%CI 0.48–1.70) | p = 0.758 |
Dihydrotestosterone | ||||||
 Cox regression analyses |  |  | 1.78 (95%CI 0.60–5.25) | p = 0.296 | 1.20 (95%CI 0.56–2.59) | p = 0.638 |